ArticleCureus2025
Iatrogenic Myocardial Stunning: The After-Effects of Electrical Cardioversion.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atrial Fibrillation Risk Management and Emerging Therapies.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrical cardioversion (ECV) is generally a safe therapy for ventricular tachycardia in unstable patients, however, associated with several complications. Potential mechanisms include myocardial stunning, rapid changes in cardiac output, and stress-induced global cardiomyopathy. We report a case of cardiogenic shock with multisystem dysfunction, likely due to myocardial stunning, in a patient who received multiple ECV treatments for electrical storm. While transient atrial stunning post-ECV is well known, severe biventricular dysfunction, though rare, is possible. This case highlights the possibility of cardiogenic shock due to myocardial stunning from ECV treatment and underscores the importance of an aggressive multidisciplinary approach to management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.